FilingIndex
DEF 14AThe Ballot

IOVANCE BIOTHERAPEUTICS, INC. files DEF 14A

Filed Apr 28, 2025 · 1y ago · Accession 0001558370-25-005702

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
IOVA
CIK
1425205
Form type
DEF 14A
Filing date
Apr 28, 2025
Report date
Jun 10, 2025
Document
iova-20250610xdef14a.htm
Size
3.9 MB